232413 Effective Treatments for PTSD in Women with SUD

Wednesday, November 10, 2010 : 10:30 AM - 10:55 AM

Denise Hien, PhD , CUNY Department of Pyschology; Columbia University College of Physicians and Surgeons, City University of New York at CCNY; Columbia University, New York, NY
        
PTSD is a common co-morbidity in the SUD population. It is estimated that 80% of women in treatment for SUD have suffered physical, emotional or sexual trauma, and that they present special needs that affect their success in achieving the goals of addictions treatment. Dr. Hien led a clinical trial in the CTN that compared a trauma-directed behavioral therapy, Seeking Safety (SS), to a more general behavioral intervention, Women's Health Education. Both treatments reduced PTSD symptoms and drug use; however, secondary analyses are beginning to reveal differences among subtypes of participants in the effectiveness of the two approaches, which have significant clinical implications. Dr. Hien will present a comprehensive overview to the best approaches for treating women with co-occurring PTSD and SUD.

Learning Areas:
Implementation of health education strategies, interventions and programs
Public health or related research
Social and behavioral sciences

Learning Objectives:
Describe the translational research activities of the NIDA Clinical Trials Network, particularly those done in partnership with SAMHSA Discuss effective treatment of PTSD and substance use; 1 of the "blending products" developed from research trials sponsored by the NIDA Clinical Trials Network Discuss the NIDA/SAMHSA "fast track" initiative to bring evidence-based treatments into clinical practice more quickly

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I AM THE PRINCIPAL Investigator of the multisite randomized clinical trial that will be presented.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 5091.0: 25th Anniversary of Alcohol Tobacco & Other Drugs Section and 10th Anniversary of the NIDA Clinical Trials Network: Progress Together